New precision medicine trial shows promise for treating rare brain tumors

Pfiz­er is set to stop con­struc­tion of a man­u­fac­tur­ing fa­cil­i­ty start­ed by Seagen in Wash­ing­ton state, with af­fect­ed em­ploy­ees pos­si­bly mov­ing to oth­er fa­cil­i­ties, a

Lau­ra Shawver pic­tures a world 10 years from now where cell ther­a­pies are re­placed by in vi­vo CAR-T prod­ucts. The goal is a cheap­er-to-pro­duce, less